GlyderTech, Inc.
Developer of a bioelectronic sensor diagnostic system based on bio-MEMS/NEMS cantilever technology for rapid, direct sample-to-answer detection of biological targets. The company focuses on sensor design, bioreceptor attachment, prototype integration, mobile-app readout, validation of detection performance (including COVID-19), and preparation for small-scale production and regulatory authorization.
Industries
N/A
Nr. of Employees
small (1-50)
GlyderTech, Inc.
Products
Disposable test cartridge and cantilever sensor system
A diagnostic system combining disposable cartridges containing NEMS cantilever sensors with electronic readout and a mobile app to report results from unprocessed samples.
Disposable test cartridge and cantilever sensor system
A diagnostic system combining disposable cartridges containing NEMS cantilever sensors with electronic readout and a mobile app to report results from unprocessed samples.
Services
Partnerships for research, prototype development, and assay adaptation of cantilever-based biosensors.
Integration of sensors, disposable cartridges, and mobile readout with performance and validation testing across sample types.
Partnerships for research, prototype development, and assay adaptation of cantilever-based biosensors.
Integration of sensors, disposable cartridges, and mobile readout with performance and validation testing across sample types.
Expertise Areas
- Biosensor development
- Bio-MEMS/NEMS sensor engineering
- Bioreceptor surface chemistry and attachment
- Rapid point-of-care diagnostics
Key Technologies
- Bio-MEMS / NEMS cantilever sensors
- Piezoresistive cantilevers
- Bioreceptor surface functionalization
- Near-field communication to mobile devices
News & Updates
Reported detection tests using nine sample types, each tested multiple times across NEMS sensors (over 1,200 tests) that reportedly showed consistent detection of SARS-CoV-2 and no signal for negative controls or non-COVID coronaviruses.
Reported detection tests using nine sample types, each tested multiple times across NEMS sensors (over 1,200 tests) that reportedly showed consistent detection of SARS-CoV-2 and no signal for negative controls or non-COVID coronaviruses.